LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | HG-6-64-01 | 0.04 | uM | LJP6 | 2 | M06 | 72 | hr | 1401 | 4394 | 4095 | 1.0729 | 1.0931 |
| SK-BR-3 | HG-6-64-01 | 0.04 | uM | LJP6 | 3 | M06 | 72 | hr | 1401 | 4347 | 4272 | 1.0175 | 1.0217 |
| SK-BR-3 | HG-6-64-01 | 0.12 | uM | LJP6 | 1 | M05 | 72 | hr | 1401 | 3331 | 4139 | 0.8048 | 0.7404 |
| SK-BR-3 | HG-6-64-01 | 0.12 | uM | LJP6 | 2 | M05 | 72 | hr | 1401 | 3732 | 4095 | 0.9113 | 0.8834 |
| SK-BR-3 | HG-6-64-01 | 0.12 | uM | LJP6 | 3 | M05 | 72 | hr | 1401 | 3569 | 4272 | 0.8354 | 0.7883 |
| SK-BR-3 | HG-6-64-01 | 0.37 | uM | LJP6 | 1 | M04 | 72 | hr | 1401 | 3512 | 4139 | 0.8485 | 0.8004 |
| SK-BR-3 | HG-6-64-01 | 0.37 | uM | LJP6 | 2 | M04 | 72 | hr | 1401 | 2826 | 4095 | 0.6901 | 0.5736 |
| SK-BR-3 | HG-6-64-01 | 0.37 | uM | LJP6 | 3 | M04 | 72 | hr | 1401 | 3619 | 4272 | 0.8471 | 0.8039 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 1401 | 3033 | 4139 | 0.7328 | 0.6391 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 1401 | 3163 | 4095 | 0.7723 | 0.6924 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 1401 | 3214 | 4272 | 0.7523 | 0.6755 |
| SK-BR-3 | HG-6-64-01 | 3.33 | uM | LJP6 | 1 | M02 | 72 | hr | 1401 | 1947 | 4139 | 0.4704 | 0.2342 |
| SK-BR-3 | HG-6-64-01 | 3.33 | uM | LJP6 | 2 | M02 | 72 | hr | 1401 | 2526 | 4095 | 0.6168 | 0.4634 |
| SK-BR-3 | HG-6-64-01 | 3.33 | uM | LJP6 | 3 | M02 | 72 | hr | 1401 | 2302 | 4272 | 0.5388 | 0.3615 |
| SK-BR-3 | HG-6-64-01 | 10 | uM | LJP6 | 1 | M01 | 72 | hr | 1401 | 369 | 4139 | 0.0892 | -0.5744 |
| SK-BR-3 | HG-6-64-01 | 10 | uM | LJP6 | 2 | M01 | 72 | hr | 1401 | 631 | 4095 | 0.1541 | -0.4030 |
| SK-BR-3 | HG-6-64-01 | 10 | uM | LJP6 | 3 | M01 | 72 | hr | 1401 | 548 | 4272 | 0.1283 | -0.4423 |
| SK-BR-3 | Neratinib | 0.04 | uM | LJP5 | 1 | A18 | 72 | hr | 1401 | 1374 | 3978 | 0.3454 | -0.0131 |
| SK-BR-3 | Neratinib | 0.04 | uM | LJP5 | 2 | A18 | 72 | hr | 1401 | 1725 | 4213 | 0.4094 | 0.1397 |
| SK-BR-3 | Neratinib | 0.04 | uM | LJP5 | 3 | A18 | 72 | hr | 1401 | 1515 | 4545 | 0.3333 | 0.0469 |
| SK-BR-3 | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 1401 | 1416 | 3978 | 0.3559 | 0.0068 |
| SK-BR-3 | Neratinib | 0.12 | uM | LJP5 | 2 | A17 | 72 | hr | 1401 | 1574 | 4213 | 0.3736 | 0.0758 |
| SK-BR-3 | Neratinib | 0.12 | uM | LJP5 | 3 | A17 | 72 | hr | 1401 | 1544 | 4545 | 0.3396 | 0.0587 |
| SK-BR-3 | Neratinib | 0.37 | uM | LJP5 | 1 | A16 | 72 | hr | 1401 | 1455 | 3978 | 0.3657 | 0.0252 |
| SK-BR-3 | Neratinib | 0.37 | uM | LJP5 | 2 | A16 | 72 | hr | 1401 | 1327 | 4213 | 0.3150 | -0.0338 |